| Literature DB >> 28893243 |
Joseph B Babigumira1,2, Solomon J Lubinga3,4, Alisa M Jenny3, Erin Larsen-Cooper5, Jessica Crawford6, Charles Matemba6, Andy Stergachis3,4.
Abstract
Entities:
Keywords: Diarrhea; Essential medicines; Health workforce; Impact evaluation; Malaria; Malawi; Pneumonia; Quasi-experiment; Supply chain
Mesh:
Substances:
Year: 2017 PMID: 28893243 PMCID: PMC5594492 DOI: 10.1186/s12913-017-2530-7
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Fig. 1Quasi-experimental design of the impact evaluation of pharmacy assistant training and deployment in Malawi. PA—pharmacy assistant; I—Intervention; C—comparison; X—timing of intervention. Adapted from Lubinga et al. [22]
Demographic and clinical characteristics
| Intervention | Comparison | Total | |
|---|---|---|---|
| Age of child, years, mean (SD) | 2.34 (1.3) | 2.15 (1.3) | 2.25 (1.3) |
| Male child, n (%) | 843 (48.9%) | 991 (50.7%) | 1834 (49.9%) |
| Number of persons in household, mean (SD) | 5.39 (1.8) | 5.24 (1.8) | 5.32 (1.8) |
| Age of primary caregiver, mean (SD) | 29.11 (7.9) | 29.15 (8.6) | 29.13 (8.3) |
| Female primary caregiver, n (%) | 1765 (97.8%) | 2008 (98.7%) | 3810 (98.3%) |
| Education level of primary caregiver | |||
| None, n (%) | 348 (20.2%) | 187 (9.6%) | 535 (14.6%) |
| Primary, n (%) | 1263 (73.5%) | 1487 (76.4%) | 2750 (75.1%) |
| Above primary, n (%) | 106 (6.1%) | 270 (13.8%) | 376 (10.2%) |
| Socioeconomic status quantile | |||
| Highest, n (%) | - | - | - |
| Second Highest, n (%) | 421 (24.4%) | 292 (14.9%) | 713 (19.4%) |
| Middle, n (%) | 927 (53.8%) | 884 (45.2%) | 1811 (49.2%) |
| Second Lowest, n (%) | 324 (18.8%) | 561 (28.7%) | 885 (24.0%) |
| Lowest, n (%) | 49 (2.8%) | 217 (11.1%) | 266 (7.2%) |
| Child’s symptoms in last two weeks | |||
| Fever, n (%) | 1390 (76.3%) | 1676 (80.8%) | 3096 (78.7%) |
| Cough, n (%) | 515 (28.3%) | 578 (27.8%) | 1101 (28.0%) |
| Diarrhea, n (%) | 783 (43.0%) | 898 (43.3%) | 1697 (43.2%) |
Regression analyses
| Any antimalarial | AL | Antibiotic | ORS | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | |||||||||||||
| Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | Unadj | Adj | |
| Constant | −0.285** | −0.624** | −0.285** | −0.625** | −0.285** | −0.611** | −0.587*** | −1.097*** | −0.587*** | −1.100*** | −0.587*** | −1.088*** | 0.869*** | 0.951** | 0.869*** | 0.947** | 0.869*** | 0.949** | −0.613*** | −0.975** | −0.613*** | −0.929** | −0.613*** | −0.925** |
| (0.116) | (0.255) | (0.116) | (0.254) | (0.116) | (0.253) | (0.092) | (0.247) | (0.092) | (0.244) | (0.092) | (0.244) | (0.160) | (0.445) | (0.160) | (0.446) | (0.160) | (0.446) | (0.175) | (0.417) | (0.175) | (0.424) | (0.175) | (0.424) | |
| Intervention | −0.222 | −0.188 | −0.222 | −0.187 | −0.222 | −0.188 | −0.010 | 0.026 | −0.010 | 0.029 | −0.010 | 0.028 | −0.199 | −0.513** | −0.199 | −0.513** | −0.199 | −0.513** | 0.208 | 0.121 | 0.208 | 0.116 | 0.208 | 0.113 |
| (0.180) | (0.169) | (0.180) | (0.169) | (0.180) | (0.169) | (0.170) | (0.163) | (0.170) | (0.163) | (0.170) | (0.163) | (0.234) | (0.245) | (0.234) | (0.245) | (0.234) | (0.245) | (0.261) | (0.268) | (0.261) | (0.268) | (0.261) | (0.269) | |
| Post Intervention | 0.045 | 0.019 | 0.252* | 0.230* | −0.420** | −0.453** | 0.315 | 0.339 | ||||||||||||||||
| (0.156) | (0.156) | (0.133) | (0.138) | (0.211) | (0.213) | (0.219) | (0.230) | |||||||||||||||||
| Intervention* Post-Intervention | 0.590** | 0.565** | 0.588** | 0.560** | 0.374* | 0.335 | 0.364 | 0.323 | −0.123 | −0.078 | −0.133 | −0.087 | −0.339 | −0.297 | −0.298 | −0.251 | ||||||||
| (0.234) | (0.224) | (0.235) | (0.225) | (0.222) | (0.216) | (0.223) | (0.217) | (0.306) | (0.307) | (0.308) | (0.308) | (0.298) | (0.302) | (0.305) | (0.309) | |||||||||
| year 2015 | 0.026 | −0.014 | −0.085 | −0.123 | 0.172 | 0.132 | 0.082 | 0.042 | −0.329 | −0.362 | −0.379 | −0.395 | 0.543** | 0.582** | 0.392 | 0.422* | ||||||||
| (0.176) | (0.177) | (0.206) | (0.209) | (0.146) | (0.152) | (0.166) | (0.173) | (0.249) | (0.246) | (0.270) | (0.274) | (0.228) | (0.236) | (0.243) | (0.253) | |||||||||
| year 2016 | 0.062 | 0.051 | 0.169 | 0.157 | 0.328** | 0.324** | 0.413** | 0.410** | −0.488** | −0.524** | −0.451* | −0.500** | 0.046 | 0.051 | 0.227 | 0.251 | ||||||||
| (0.164) | (0.163) | (0.176) | (0.175) | (0.151) | (0.155) | (0.170) | (0.174) | (0.221) | (0.227) | (0.233) | (0.233) | (0.244) | (0.254) | (0.253) | (0.267) | |||||||||
| year 2015* Intervention | 0.794*** | 0.762*** | 0.529** | 0.488* | −0.054 | −0.036 | −0.002 | 0.070 | ||||||||||||||||
| (0.282) | (0.281) | (0.251) | (0.252) | (0.361) | (0.375) | (0.350) | (0.353) | |||||||||||||||||
| year 2016* Intervention | 0.409 | 0.384 | 0.223 | 0.179 | −0.197 | −0.130 | −0.612* | −0.597* | ||||||||||||||||
| (0.264) | (0.251) | (0.262) | (0.253) | (0.374) | (0.359) | (0.332) | (0.341) | |||||||||||||||||
| N | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 2873 | 1036 | 1036 | 1036 | 1036 | 1036 | 1036 | 1552 | 1552 | 1552 | 1552 | 1552 | 1552 |
| Log-Likelihood | −1963 | −1922 | −1963 | −1921 | −1961 | −1919 | −1939 | −1893 | −1938 | −1891 | −1937 | −1889 | −679 | −653 | −678 | −652 | −678 | −652 | −1041 | −1022 | −1033 | −1014 | −1031 | −1010 |
| AIC | 3935 | 3871 | 3937 | 3873 | 3935 | 3871 | 3887 | 3813 | 3886 | 3811 | 3885 | 3810 | 1365 | 1333 | 1366 | 1335 | 1368 | 1337 | 2090 | 2072 | 2077 | 2057 | 2073 | 2053 |
AL Artemether Lumefantrine, ORS Oral Rehydration Salts, Unadj unadjusted models, Adj models adjusted for child’s age and sex, care giver’s age and sex, level of education and marital status, and the household socioeconomic status (wealth index)
* p < 0.1; ** p < 0.05; *** p < 0.01
Fig. 2Impact of pharmacy assistant training and deployment. The dotted line represents the timing of the intervention